CONCLUSIONS: When given before renal ischemia, the acellular secretome of mesenchymal stem cells improves recovery of renal function following ischemia-reperfusion injury. This improvement occurs despite route of administration, suggesting the therapy functions by a systemic effect. The aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs (AD-MSCs) in peritoneal dialysis (PD) patients with expected peritoneal fibrosis.
INTRODUCTION AND OBJECTIVES: Adverse effects of radiation include urothelial hemorrhage and bladder fibrosis. Mesenchymal stem cells are known to promote tissue repair and inhibit inflammation. Our aim was to investigate the effect of intradetrusor iPSC-derived human progenitor smooth muscle cells (pSMC) in a rat model of radiation cystitis.
METHODS: Twenty-four female Rowett nude rat bladders were irradiated on day 0 [n[6 (0Gy); n[18 (20Gy)]. On day 53, randomizedblinded intradetrusor injection was performed ]. Nocturnal void volume was measured using metabolic cages biweekly (day 0-81). 4-weeks after injection (day 81), bladders were assessed by cystometry, organ bath and histology. Data were analyzed in SAS.
RESULTS: There were 1,242 nocturnal voids (146 cage cycles, 7 time points). Volume per void was immediately reduced after irradiation. There was 28% (5/18) mortality from radiation proctitis (day 28-51). Following injection, survival of cells was confirmed by luciferase bioluminescence imaging. Nocturnal mean voided volume was partially improved in 20Gy-pSMC rats at 2-weeks after injection. After pSMC injection (day 51-81), there was normalization in number of voids (r [-0.03, p[0.892), total urine production (r[0.01, p[0.96) and stool output (r [-0.15, p[0.53) . On multivariate linear regression, after adjusting for covariates (water intake, total urine output, rat weight, stool output), there was a reduction in voided volume after vehicle injection (p<0.05, ref 0Gy), and partial improvement after pSMC injection (p[0.19, ref 0Gy) [LS-means: 0.50mL (0Gy), 0.42mL (20Gy-Vehicle), 0.45mL (20Gy-pSMC)]. On cystometry, irradiation resulted in poor voiding efficiency (VE<15%) in 100% (4/4) of vehicle rats. The majority (67%, 4/6) of non-irradiated bladders had efficient voids (VE>20%). Improved voiding (VE>30%) was noted in 80% (4/ 5) of rats at 4-weeks after pSMC injection (day 81). On organ bath myography (day 81), irradiation weakened carbachol response in all tissues. pSMC bladder strips demonstrated partial improvement in potassium-chloride response (100-200mM) and sustained increase in electrical field stimulation contractility at 64Hz [mean tension 1.21g (20Gy-pSMC) vs. 0.84g (0Gy), p[0.12]. On histology, human nuclei colocalized with smoothelin, a marker of smooth muscle.
CONCLUSIONS: Following pelvic irradiation, pSMC intradetrusor injection partially improved ambulatory mean voided volume, cystometric voiding efficiency, potassium-chloride response and electrical field stimulation contractility.
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PD09-07 ENHANCED DIFFERENTIATION AND STRATIFICATION OF BLADDER UROTHELIUM FROM HUMAN INDUCED PLURIPOTENT STEM CELL
Kotaro Suzuki*, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Nobuyuki Hinata, Masato Fujisawa, Takashi Aoi, Kobe, Japan INTRODUCTION AND OBJECTIVES: Patients with bladder diseases often require augmentation or reconstruction of urinary bladder. Although gastrointestinal tissue or autologous bladder cells have been employed in treatments for the regeneration of bladder functions, these approaches often cause various adverse events. Recently, bladder urothelium derived from human induced pluripotent stem cells (hiPSCs) has received focus. However, previous studies have only shown the emergence of cells expressing some urothelial markers among derivatives of hiPSCs. This study aimed to develop a protocol for the directed differentiation of hiPSCs into mature stratified bladder urothelium.
METHODS: We evaluated the effect of several small molecules, FGF10 and culture devices on the urothelial differentiation of hiPSCs by assessing markers from initial to terminal differentiation stage as well as formation of stratified structure. The marker gene expression was analyzed by Reverse transcription polymerase chain reaction (RT-PCR) and immunocytochemistry. To assess stratification, we employed optical coherence tomography (OCT) imaging.
RESULTS: The caudal hindgut, from which the bladder urothelium develops, was predominantly induced via the high-dose administration of CHIR99021 during definitive endoderm induction, and this treatment subsequently increased the expressions of uroplakins. Terminal differentiation, characterized by the increased expression of uroplakins, CK13 and CK20, was induced with the combination of Troglitazone and PD153035. FGF10 not only increased the expression of uroplakins but also enhanced Vol. 201, No. 4S, Supplement, Friday, May 3, 2019 THE JOURNAL OF UROLOGY Ò e155
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